THOMAS R STAAB II Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for THOMAS R STAAB II.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of THOMAS R STAAB II. THOMAS R STAAB II is a Senior Vice President and CFO in BIOCRYST PHARMACEUTICALS INC ($BCRX).

Address: 4505 EMPEROR BLVD. SUITE 200 DURHAM 27703 NC

Companies in which THOMAS R STAAB II is an Insider

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of THOMAS R STAAB II: Senior Vice President and CFO
Holdings: 164,913 shares
Current Value: $935,057
Latest Transaction: Jan 22 2015
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of THOMAS R STAAB II

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 22 2015BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Payment of ExerciseF11.174,47649,997164,913169.4 K to 164.9 K (-2.64 %)
Jan 05 2015BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseA12.1642,400515,58442,400
Jan 05 2015BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Payment of ExerciseF12.162,45329,828169,389171.8 K to 169.4 K (-1.43 %)
Jan 05 2015BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...GrantA0.008,9000171,842162.9 K to 171.8 K (+5.46 %)
Dec 31 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM3.789,50035,910111,135
Dec 31 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS12.569,500119,320162,942172.4 K to 162.9 K (-5.51 %)
Dec 31 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM3.789,50035,910172,442162.9 K to 172.4 K (+5.83 %)

View all THOMAS R STAAB II insider transactions.